ArriVent BioPharma, Inc. (AVBP) Q1 2024 Earnings
AVBP·Reported May 8, 2024·Before market open
Diluted EPS came in at $-0.70, beat the $-0.84 consensus by $0.14.
Diluted EPS
$-0.70beat by $0.14
Consensus: $-0.84
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about ArriVent BioPharma, Inc.'s Q1 2024 earnings report.
ArriVent BioPharma, Inc. (AVBP) reported Q1 2024 earnings on May 8, 2024 before market open.
ArriVent BioPharma, Inc. reported diluted EPS of $-0.70 for Q1 2024.
EPS beat the consensus estimate of $-0.84 by $0.14.
You can read the 10-Q periodic report (0001558370-24-007197) directly on SEC EDGAR. The filing index links above go to sec.gov.